Anavex Life Sciences Statistics
Total Valuation
AVXL has a market cap or net worth of $697.91 million. The enterprise value is $591.11 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, before market open.
Earnings Date | May 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AVXL has 85.37 million shares outstanding. The number of shares has increased by 3.60% in one year.
Current Share Class | 85.37M |
Shares Outstanding | 85.37M |
Shares Change (YoY) | +3.60% |
Shares Change (QoQ) | +0.32% |
Owned by Insiders (%) | 3.29% |
Owned by Institutions (%) | 36.70% |
Float | 82.56M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 6.92 |
P/TBV Ratio | 7.09 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.74
Current Ratio | 6.74 |
Quick Ratio | 6.70 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -40.17% and return on invested capital (ROIC) is -28.36%.
Return on Equity (ROE) | -40.17% |
Return on Assets (ROA) | -25.44% |
Return on Invested Capital (ROIC) | -28.36% |
Return on Capital Employed (ROCE) | -53.37% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.12M |
Employee Count | 42 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +104.89% in the last 52 weeks. The beta is 0.82, so AVXL's price volatility has been lower than the market average.
Beta (5Y) | 0.82 |
52-Week Price Change | +104.89% |
50-Day Moving Average | 8.93 |
200-Day Moving Average | 7.99 |
Relative Strength Index (RSI) | 40.76 |
Average Volume (20 Days) | 708,206 |
Short Selling Information
The latest short interest is 23.49 million, so 27.52% of the outstanding shares have been sold short.
Short Interest | 23.49M |
Short Previous Month | 24.01M |
Short % of Shares Out | 27.52% |
Short % of Float | 28.45% |
Short Ratio (days to cover) | 23.56 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -53.24M |
Pretax Income | -41.47M |
Net Income | -47.14M |
EBITDA | n/a |
EBIT | -53.24M |
Earnings Per Share (EPS) | -$0.56 |
Full Income Statement Balance Sheet
The company has $115.77 million in cash and n/a in debt, giving a net cash position of $115.77 million or $1.36 per share.
Cash & Cash Equivalents | 115.77M |
Total Debt | n/a |
Net Cash | 115.77M |
Net Cash Per Share | $1.36 |
Equity (Book Value) | 99.76M |
Book Value Per Share | 1.17 |
Working Capital | 99.76M |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
AVXL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.60% |
Shareholder Yield | -3.60% |
Earnings Yield | -6.67% |
FCF Yield | n/a |
Analyst Forecast
The average price target for AVXL is $44.00, which is 438.23% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $44.00 |
Price Target Difference | 438.23% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on October 7, 2015. It was a reverse split with a ratio of 0.25:1.
Last Split Date | Oct 7, 2015 |
Split Type | Reverse |
Split Ratio | 0.25:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |